All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2026-P-4762
Requests that the FDA Require ANDA 220582 to be supported with in vivo bioequivalence data from a study involving the product for which approval is being sought under the ANDA; Require ANDA 220582 and other ANDAs that reference BELBUCA to include data and information justifying the entire pH range in the product specifications to ensure that intentional changes to pH compared to BELBUCA.
Documents
36
Comments
0
Key Dates
Comment Period OpensMay 1, 2026
Documents
| Type | Title | Status |
|---|---|---|
Supporting Material |
Keywords
CDER
Citizen Petition
Collegium Pharmaceutical Inc
Require ANDA 220582
be supported with in vivo bioequivalence
data from a study involving the product
which approval is being sought under the ANDA
Require ANDA 220582 and other ANDAs
Data from Regulations.gov